AVIGBAGENE PARVEC GENOME SEQUENCE ENCODING BETA-GLUCOCEREBROSIDASE, VARIANT (351-CYSTEINE, 380-CYSTEINE) TRANSGENE
UNII P6WZU2AVG7
Substance Identification & Data
This profile provides standardized clinical and technical data for Avigbagene Parvec Genome Sequence Encoding Beta-glucocerebrosidase, Variant (351-cysteine, 380-cysteine) Transgene, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P6WZU2AVG7.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3052952-55-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Avigbagene Parvec Genome Sequence Encoding Beta-glucocerebrosidase, Variant (351-cysteine, 380-cysteine) Transgene. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.